Carlos Graux

Fingerprint Dive into the research topics where Carlos Graux is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

24 Similar Profiles

Protein-Tyrosine Kinases Medicine & Life Sciences

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences

Meta-Analysis Medicine & Life Sciences

Blood Vessels Medicine & Life Sciences

Leukemia Medicine & Life Sciences

Endothelial Cells Medicine & Life Sciences

Biomarkers Medicine & Life Sciences

Atherosclerosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2013 2016

2 Finished
3 Active

Etude miR-126 impliqué en oncogenèse

Muylkens, B., Graux, C., George, F. & Finet, L.

1/12/13 → …

Project: Research

Implication d’un gène candidat dans la chimiorésistance de lignées issues de carcinomes spinocellulaires en conditions hypoxiques

Graux, C. & Poumay, Y.

1/12/13 → …

Project: Research

Test sanguin de détection/pronostic de cancer

Popa, C., De Ronde, T., Rahier, J., D'Hondt, L., Graux, C., George, F., Finet, L. & Herzog, M.

1/12/13 → …

Project: Research

Etude de l’effet potentiel de macrophages sur la cytotoxicité de molécules chimiothérapeutiques vis-à-vis de cellules cancéreuses

Graux, C., Michiels, C. & Genin, M.

1/12/13 → 30/09/14

Project: Research

Télévie: Etude de la résistance des tumeurs aux agents utilisés en chimiothérapie : caractérisation et validation d’un gène candidat

Michiels, C., Graux, C., D'Hondt, L., George, F. & Finet, L.

1/12/13 → 30/09/16

Project: Research

Research Output 2012 2019

106 Citations
4 h-Index
9 Article
7 Poster
5 Conference contribution
1 Review article

An updated meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia

Haguet, H., Mullier, F., Graux, C., Dogne, J-M. & Douxfils, J., 13 Jun 2019.

Research output: Contribution to conference › Poster

Characterization of the role of TMEM45A in cancer cell sensitivity to cisplatin

Schmit, K., Chen, J-W., Ayama-Canden, S., Fransolet, M., Finet, L., Demazy, C., D’Hondt, L., Graux, C. & Michiels, C., 2019, In : Cell Death and Disease. 10, 12, 18 p., 919.

Research output: Contribution to journal › Article

Open Access

File

Cisplatin

Neoplasms

RNA Sequence Analysis

Apoptosis Regulatory Proteins

Proteins

In vitro investigations of the effect of BCR-ABL Tyrosine Kinase Inhibitors on endothelial cell viability

Haguet, H., Graux, C., Dogne, J-M., Mullier, F. & Douxfils, J., Jan 2019.

Research output: Contribution to conference › Poster

1 Downloads (Pure)

BCR-ABL Tyrosine Kinase Inhibitors: Which Mechanism(s) May Explain the Risk of Thrombosis?

Haguet, H., Douxfils, J., Chatelain, C., Graux, C., Mullier, F. & Dogne, J-M., 2018, In : TH Open. 02, 1, p. e68-e88

Research output: Contribution to journal › Review article

Open Access

File

Circulating MicroRNAs as Biomarkers in Diffuse Large B-cell Lymphoma: A Pilot Prospective Longitudinal Clinical Study

Bouvy, C., Wannez, A., George, F., Graux, C., Chatelain, C. & Dogné, J-M., 18 Jan 2018, In : Biomarkers in cancer. 10, p. 1179299X18781095

Research output: Contribution to journal › Article

Open Access

Lymphoma, Large B-Cell, Diffuse

MicroRNAs

Longitudinal Studies

Biomarkers

Clinical Studies

Datasets

Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis

Graux, C. (Contributor), Figshare, 29 Nov 2016

DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)

Dataset

Activities 2015 2019

6 Oral presentation